Detalhe da pesquisa
1.
How I treat transplant-eligible patients with myelofibrosis.
Blood
; 142(20): 1683-1696, 2023 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37647853
2.
Clinical decision-making and treatment of myelodysplastic syndromes.
Blood
; 142(26): 2268-2281, 2023 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37874917
3.
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation.
Blood
; 141(23): 2901-2911, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36940410
4.
Upper and/or Lower Respiratory Tract Infection Caused by Human Metapneumovirus After Allogeneic Hematopoietic Stem Cell Transplantation.
J Infect Dis
; 229(1): 83-94, 2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37440459
5.
Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study.
Blood
; 140(14): 1635-1649, 2022 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35344580
6.
Allogeneic hematopoietic stem cell transplantation in patients aged 60-79 years in Germany (1998-2018): a registry study.
Haematologica
; 109(2): 431-443, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646665
7.
Allogeneic hematopoetic stem cell transplant for patients with refractory T-Cell lymphomas.
Eur J Haematol
; 112(2): 276-285, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37845834
8.
Impact of busulfan versus treosulfan dose intensity in myelofibrosis undergoing hematopoietic cell transplantation.
Am J Hematol
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38742955
9.
Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide versus conventional anti-graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Am J Hematol
; 2024 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38856236
10.
Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1-mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party.
Am J Hematol
; 99(3): 360-369, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38165072
11.
Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT.
Am J Hematol
; 99(2): 203-215, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38009469
12.
Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: A global collaborative analysis.
Am J Hematol
; 99(5): 844-853, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38357714
13.
Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMT.
Am J Hematol
; 99(5): 993-996, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385579
14.
Unrelated or haploidentical allogeneic hematopoietic cell transplantation in second complete remission for acute myeloid leukemia-Improved outcomes over time: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party study.
Cancer
; 129(17): 2645-2654, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269074
15.
Posttransplant cyclophosphamide versus antithymocyte globulin in patients with acute lymphoblastic leukemia treated with allogeneic hematopoietic cell transplantation from matched unrelated donors: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Cancer
; 129(23): 3735-3745, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37658621
16.
Outcomes after allogeneic haematopoietic stem cell transplantation in young adults in Germany.
Br J Haematol
; 201(2): 308-318, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36573337
17.
Molecular monitoring of T-cell kinetics and migration in severe neurotoxicity after real-world CD19-specific chimeric antigen receptor T cell therapy.
Haematologica
; 108(2): 444-456, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35950534
18.
Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial.
Haematologica
; 108(11): 3001-3010, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37259567
19.
Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modeling.
Haematologica
; 108(4): 1105-1114, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35770529
20.
Autologous-allogeneic versus autologous tandem stem cell transplantation and maintenance therapy with thalidomide for multiple myeloma patients less than 60 years of age: a prospective phase II study
Haematologica
; 2023 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37941409